| TSMDX | VEMPX | TSMDX / VEMPX | |
| Total Expense Ratio | 0.97 | 0.04 | 2,771% |
| Annual Report Gross Expense Ratio | 1.11 | 0.04 | 3,171% |
| Fund Existence | 11 years | 16 years | - |
| Gain YTD | 8.874 | 13.066 | 68% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 100000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 33M | 97.7B | 0% |
| Annual Yield % from dividends | 0.00 | 1.05 | - |
| Returns for 1 year | 15.00 | 19.76 | 76% |
| Returns for 3 years | 15.94 | 51.94 | 31% |
| Returns for 5 years | 4.64 | 28.31 | 16% |
| Returns for 10 years | 76.38 | 175.95 | 43% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LAVSX | 17.56 | 0.03 | +0.17% |
| Lord Abbett Fundamental Equity R4 | |||
| DGSCX | 38.53 | -0.09 | -0.23% |
| Virtus KAR Global Small-Cap Inst | |||
| BROIX | 25.01 | -0.16 | -0.64% |
| BlackRock Advantage International Instl | |||
| ECHSX | 13.24 | -0.15 | -1.12% |
| Eaton Vance Worldwide Health Sci C | |||
| MSSGX | 16.32 | -0.20 | -1.21% |
| Morgan Stanley Inst Inception I | |||